
Sign up to save your podcasts
Or


In this episode, we discuss the therapeutic drug monitoring and dose adjustments for valproic acid (Depakote/Depakene/Depakon) and digoxin (Lanoxin).
In this episode, we discuss the therapeutic drug monitoring and dose adjustments for warfarin (Coumadin) and phenytoin (Dilantin).
In this episode, we discuss malaria prophylaxis with atovaquone/proguanil, chloroquine, hydroxychloroquine, doxycycline, mefloquine, and primaquine.
In this episode, we discuss six pivotal drug classes that have been FDA approved within the past 20 years. This is part 2 of a 2 part episode.
In this episode, we discuss six pivotal drug classes that have been FDA approved within the past 20 years. This is part 1 of a 2 part episode.
In this episode, we interview Brad Cannon, PharmD regarding his career path in pharmacy and his viewpoints on the pharmacy profession.
In this episode, we discuss the optimal drug therapy for three different case vignettes -- depression, hypertension, and diabetes mellitus.
In this episode, we review historical and new treatment options for hepatitis C, including: peginterferon, rivabirin, boceprevir, telaprevir, sofosbuvir (Sovaldi), simeprevir (Olysio), ombitasvir/paritaprevir/ritonavir/dasabuvir (Viekira Pak), and ledipasvir/sofosbuvir (Harvoni).
May 18, 2015 - Correction added in the beginning of the episode regarding Viekira Pak dosing regimen.
In this episode, we discuss the pharmacology of oversedation, the importance of sedation minimization strategies in mechanically ventilated patients, and overview the sedatives and analgesics commonly used in this patient population.
In this episode, we discuss risk factors for opioid-related adverse events, naloxone (Narcan, Evzio), and a number of non-narcotic agents for neuropathic pain.
From the publisher's feed

43,307 Listeners

694 Listeners

499 Listeners

264 Listeners

3,343 Listeners

56,398 Listeners

1,157 Listeners

16,947 Listeners

402 Listeners

733 Listeners

299 Listeners

195 Listeners

516 Listeners

108 Listeners

155 Listeners